GEDAX Fees and Costs — GMO Emerging Domestic Opportunities Series Fund, Class PS

Data updated: 2021-01-29

The net expense ratio is 1.15% (1.92% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 7%.

GEDAX Fees and Expenses

Annual operating expenses and sales charges of GEDAX. Prospectus, as of February 29, 2020.

Annual operating expenses
Management fee0.90%
12b-1 fee0.00%
Other expenses0.73%
Gross expense ratio1.92%
Fee waiver−0.77%
Net expense ratio1.15%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

GEDAX Costs Over Time

On $10,000 invested in GEDAX, assuming 5% a year before costs, total costs come to $717 over 5 years, cutting the return by 1.21% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.15%)$121$376$651
Lost growth on money paid in costs$0$19$66
Total costs$121$395$717
Value after costs$10,379$11,181$12,046
Impact on return, per year1.21%1.21%1.21%

GEDAX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 29, 2020.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $2.3M
  • Portfolio turnover (prospectus): 7%
  • Securities lending: none during the year

GEDAX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
State Street Bank and Trust Company$2.3M100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.